{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"5.3","upperLimit":"85.3","value":"40.0"},{"groupId":"OG001","lowerLimit":"35.9","upperLimit":"99.6","value":"83.3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"description":"Objective Response Rate (ORR) is defined as the percentage of participants with complete response (CR) or partial response (PR) according to the modified Lugano Criteria for Response Assessment (Cheson 2014) based on BICR","dispersionType":"95% Confidence Interval","groups":[{"description":"Participants with classic Hodgkin lymphoma","id":"OG000","title":"Classic Hodgkin Lymphoma"},{"description":"Participants with peripheral T cell lymphoma","id":"OG001","title":"PTCL"}],"paramType":"NUMBER","populationDescription":"The full analysis set includes participants who received at least one dose of study treatment.","reportingStatus":"POSTED","timeFrame":"Up to 18.3 months","title":"Objective Response Rate (ORR) Per BICR According to Modified Lugano Response Criteria","type":"PRIMARY","unitOfMeasure":"percentage of participants"}